Proactiveinvestors USA & Canada Acasti Pharma Inc https://ca.proactiveinvestors.com Proactiveinvestors USA & Canada Acasti Pharma Inc RSS feed en Fri, 18 Sep 2020 22:51:56 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Acasti Pharma names Brian D. Ford as new finance chief as it explores "strategic options and opportunities" https://ca.proactiveinvestors.com/companies/news/929231/acasti-pharma-names-brian-d-ford-as-new-finance-chief-as-it-explores--strategic-options-and-opportunities--929231.html Wed, 16 Sep 2020 12:23:00 -0400 https://ca.proactiveinvestors.com/companies/news/929231/acasti-pharma-names-brian-d-ford-as-new-finance-chief-as-it-explores--strategic-options-and-opportunities--929231.html Acasti Pharma reports results from Phase 3 TRILOGY 2 study of lead drug CaPre https://ca.proactiveinvestors.com/companies/news/927891/acasti-pharma-reports-results-from-phase-3-trilogy-2-study-of-lead-drug-capre-927891.html Mon, 31 Aug 2020 13:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/927891/acasti-pharma-reports-results-from-phase-3-trilogy-2-study-of-lead-drug-capre-927891.html Acasti Pharma looking forward to the unblinding of its TRILOGY 2 trial data around end of this month https://ca.proactiveinvestors.com/companies/news/926628/acasti-pharma-looking-forward-to-the-unblinding-of-its-trilogy-2-trial-data-around-end-of-this-month-926628.html Thu, 13 Aug 2020 13:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/926628/acasti-pharma-looking-forward-to-the-unblinding-of-its-trilogy-2-trial-data-around-end-of-this-month-926628.html Acasti Pharma submits Statistical Analysis Plan to FDA for TRILOGY 2 Phase 3 trial of flagship drug CaPre https://ca.proactiveinvestors.com/companies/news/925596/acasti-pharma-submits-statistical-analysis-plan-to-fda-for-trilogy-2-phase-3-trial-of-flagship-drug-capre-925596.html Fri, 31 Jul 2020 13:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/925596/acasti-pharma-submits-statistical-analysis-plan-to-fda-for-trilogy-2-phase-3-trial-of-flagship-drug-capre-925596.html Acasti Pharma eyeing TRILOGY 2 data as it reveals phenomenon of 'triglyceride normalization' could have played part in first trial https://ca.proactiveinvestors.com/companies/news/923002/acasti-pharma-eyeing-trilogy-2-data-as-it-reveals-phenomenon-of--triglyceride-normalization--could-have-played-part-in-first-trial-923002.html Mon, 29 Jun 2020 15:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/923002/acasti-pharma-eyeing-trilogy-2-data-as-it-reveals-phenomenon-of--triglyceride-normalization--could-have-played-part-in-first-trial-923002.html Acasti Pharma considering FDA's comments after receiving response to its CaPre TRILOGY trials briefing package https://ca.proactiveinvestors.com/companies/news/922343/acasti-pharma-considering-fda-s-comments-after-receiving-response-to-its-capre-trilogy-trials-briefing-package-922343.html Fri, 19 Jun 2020 17:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/922343/acasti-pharma-considering-fda-s-comments-after-receiving-response-to-its-capre-trilogy-trials-briefing-package-922343.html Acasti Pharma hopeful of path towards New Drug Application for CaPre as it submits TRILOGY 1 package https://ca.proactiveinvestors.com/companies/news/918546/acasti-pharma-hopeful-of-path-towards-new-drug-application-for-capre-as-it-submits-trilogy-1-package-918546.html Thu, 30 Apr 2020 14:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/918546/acasti-pharma-hopeful-of-path-towards-new-drug-application-for-capre-as-it-submits-trilogy-1-package-918546.html Acasti Pharma shares lifted as it further bolsters its intellectual property portfolio https://ca.proactiveinvestors.com/companies/news/917653/acasti-pharma-shares-lifted-as-it-further-bolsters-its-intellectual-property-portfolio-917653.html Mon, 20 Apr 2020 14:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/917653/acasti-pharma-shares-lifted-as-it-further-bolsters-its-intellectual-property-portfolio-917653.html Acasti Pharma shares nudge higher as it files meeting request with the US Food and Drug Administration https://ca.proactiveinvestors.com/companies/news/916386/acasti-pharma-shares-nudge-higher-as-it-files-meeting-request-with-the-us-food-and-drug-administration-916386.html Wed, 01 Apr 2020 14:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/916386/acasti-pharma-shares-nudge-higher-as-it-files-meeting-request-with-the-us-food-and-drug-administration-916386.html Acasti Pharma eyeing FDA meeting as it continues to advance heart disease candidate CaPre https://ca.proactiveinvestors.com/companies/news/916012/acasti-pharma-eyeing-fda-meeting-as-it-continues-to-advance-heart-disease-candidate-capre-916012.html Mon, 30 Mar 2020 15:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/916012/acasti-pharma-eyeing-fda-meeting-as-it-continues-to-advance-heart-disease-candidate-capre-916012.html Acasti Pharma logs three patents in US, Mexico and Japan for flagship drug CaPre https://ca.proactiveinvestors.com/companies/news/914764/acasti-pharma-logs-three-patents-in-us-mexico-and-japan-for-flagship-drug-capre-914764.html Wed, 11 Mar 2020 15:22:00 -0400 https://ca.proactiveinvestors.com/companies/news/914764/acasti-pharma-logs-three-patents-in-us-mexico-and-japan-for-flagship-drug-capre-914764.html Acasti Pharma making 'steady progress' on CaPre trials, says CEO https://ca.proactiveinvestors.com/companies/news/912987/acasti-pharma-making--steady-progress--on-capre-trials-says-ceo-912987.html Fri, 14 Feb 2020 14:26:00 -0500 https://ca.proactiveinvestors.com/companies/news/912987/acasti-pharma-making--steady-progress--on-capre-trials-says-ceo-912987.html Acasti Pharma updates on TRILOGY 1 and TRILOGY 2 Phase 3 trials of lead heart drug CaPre https://ca.proactiveinvestors.com/companies/news/912533/acasti-pharma-updates-on-trilogy-1-and-trilogy-2-phase-3-trials-of-lead-heart-drug-capre-912533.html Mon, 10 Feb 2020 13:30:00 -0500 https://ca.proactiveinvestors.com/companies/news/912533/acasti-pharma-updates-on-trilogy-1-and-trilogy-2-phase-3-trials-of-lead-heart-drug-capre-912533.html Acasti Pharma says further analysis underway after TRILOGY 1 topline results show unexpected placebo effect https://ca.proactiveinvestors.com/companies/news/910460/acasti-pharma-says-further-analysis-underway-after-trilogy-1-topline-results-show-unexpected-placebo-effect-910460.html Mon, 13 Jan 2020 13:52:00 -0500 https://ca.proactiveinvestors.com/companies/news/910460/acasti-pharma-says-further-analysis-underway-after-trilogy-1-topline-results-show-unexpected-placebo-effect-910460.html Acasti Pharma shares on the move, expects to report TRILOGY 1 results of CaPre trial in January https://ca.proactiveinvestors.com/companies/news/909796/acasti-pharma-shares-on-the-move-expects-to-report-trilogy-1-results-of-capre-trial-in-january-909796.html Fri, 27 Dec 2019 18:35:00 -0500 https://ca.proactiveinvestors.com/companies/news/909796/acasti-pharma-shares-on-the-move-expects-to-report-trilogy-1-results-of-capre-trial-in-january-909796.html Acasti has 'put its finger on something very interesting' in new data, updates on TRILOGY trial https://ca.proactiveinvestors.com/companies/news/907910/acasti-has--put-its-finger-on-something-very-interesting--in-new-data-updates-on-trilogy-trial-907910.html Tue, 26 Nov 2019 19:42:00 -0500 https://ca.proactiveinvestors.com/companies/news/907910/acasti-has--put-its-finger-on-something-very-interesting--in-new-data-updates-on-trilogy-trial-907910.html Acasti Pharma leaps closer to TRILOGY 1 results after it wraps up patient visits https://ca.proactiveinvestors.com/companies/news/907871/acasti-pharma-leaps-closer-to-trilogy-1-results-after-it-wraps-up-patient-visits-907871.html Tue, 26 Nov 2019 14:41:00 -0500 https://ca.proactiveinvestors.com/companies/news/907871/acasti-pharma-leaps-closer-to-trilogy-1-results-after-it-wraps-up-patient-visits-907871.html Research firm Encode Ideas starts coverage on biotech Acasti Pharma https://ca.proactiveinvestors.com/companies/news/907766/research-firm-encode-ideas-starts-coverage-on-biotech-acasti-pharma-907766.html Mon, 25 Nov 2019 15:14:00 -0500 https://ca.proactiveinvestors.com/companies/news/907766/research-firm-encode-ideas-starts-coverage-on-biotech-acasti-pharma-907766.html Acasti Pharma's omega-3 drug CaPre shows potential use as type 2 diabetes treatment https://ca.proactiveinvestors.com/companies/news/907292/acasti-pharma-s-omega-3-drug-capre-shows-potential-use-as-type-2-diabetes-treatment-907292.html Mon, 18 Nov 2019 17:38:00 -0500 https://ca.proactiveinvestors.com/companies/news/907292/acasti-pharma-s-omega-3-drug-capre-shows-potential-use-as-type-2-diabetes-treatment-907292.html Acasti Pharma remains Speculative Buy following FDA win for rival's heart drug: Mackie https://ca.proactiveinvestors.com/companies/news/907207/acasti-pharma-remains-speculative-buy-following-fda-win-for-rival-s-heart-drug-mackie-907207.html Fri, 15 Nov 2019 17:22:00 -0500 https://ca.proactiveinvestors.com/companies/news/907207/acasti-pharma-remains-speculative-buy-following-fda-win-for-rival-s-heart-drug-mackie-907207.html Acasti Pharma eyeing 2021 as US launch date for lead drug CaPre https://ca.proactiveinvestors.com/companies/news/906973/acasti-pharma-eyeing-2021-as-us-launch-date-for-lead-drug-capre-906973.html Wed, 13 Nov 2019 18:00:00 -0500 https://ca.proactiveinvestors.com/companies/news/906973/acasti-pharma-eyeing-2021-as-us-launch-date-for-lead-drug-capre-906973.html Acasti Pharma says independent study highlights effectiveness of CaPre in treating hypertriglyceridemia https://ca.proactiveinvestors.com/companies/news/906549/acasti-pharma-says-independent-study-highlights-effectiveness-of-capre-in-treating-hypertriglyceridemia-906549.html Thu, 07 Nov 2019 14:52:00 -0500 https://ca.proactiveinvestors.com/companies/news/906549/acasti-pharma-says-independent-study-highlights-effectiveness-of-capre-in-treating-hypertriglyceridemia-906549.html Acasti Pharma edging closer to commercializing CaPre as it eyes topline clinical data for Christmas https://ca.proactiveinvestors.com/companies/news/906464/acasti-pharma-edging-closer-to-commercializing-capre-as-it-eyes-topline-clinical-data-for-christmas-906464.html Thu, 07 Nov 2019 12:15:00 -0500 https://ca.proactiveinvestors.com/companies/news/906464/acasti-pharma-edging-closer-to-commercializing-capre-as-it-eyes-topline-clinical-data-for-christmas-906464.html Acasti Pharma signs long term deal with Aker Bio Marine to deliver Krill Oil https://ca.proactiveinvestors.com/companies/news/906358/acasti-pharma-signs-long-term-deal-with-aker-bio-marine-to-deliver-krill-oil-906358.html Tue, 05 Nov 2019 16:45:00 -0500 https://ca.proactiveinvestors.com/companies/news/906358/acasti-pharma-signs-long-term-deal-with-aker-bio-marine-to-deliver-krill-oil-906358.html Acasti Pharma inks krill oil supply deal with Aker BioMarine to scale up production of its drug candidate CaPre https://ca.proactiveinvestors.com/companies/news/906254/acasti-pharma-inks-krill-oil-supply-deal-with-aker-biomarine-to-scale-up-production-of-its-drug-candidate-capre-906254.html Mon, 04 Nov 2019 19:05:00 -0500 https://ca.proactiveinvestors.com/companies/news/906254/acasti-pharma-inks-krill-oil-supply-deal-with-aker-biomarine-to-scale-up-production-of-its-drug-candidate-capre-906254.html Acasti Pharma 'marching to the goal-line' with two Phase 3 trials for its lead drug candidate CaPre https://ca.proactiveinvestors.com/companies/news/903922/acasti-pharma--marching-to-the-goal-line--with-two-phase-3-trials-for-its-lead-drug-candidate-capre-903922.html Tue, 01 Oct 2019 14:37:00 -0400 https://ca.proactiveinvestors.com/companies/news/903922/acasti-pharma--marching-to-the-goal-line--with-two-phase-3-trials-for-its-lead-drug-candidate-capre-903922.html Acasti Pharma on pace to release Phase 3 trial results of lead drug candidate CaPre in December https://ca.proactiveinvestors.com/companies/news/903787/acasti-pharma-on-pace-to-release-phase-3-trial-results-of-lead-drug-candidate-capre-in-december-903787.html Mon, 30 Sep 2019 13:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/903787/acasti-pharma-on-pace-to-release-phase-3-trial-results-of-lead-drug-candidate-capre-in-december-903787.html Acasti Pharma receives $750,000 grant from National Research Council of Canada https://ca.proactiveinvestors.com/companies/news/902328/acasti-pharma-receives-750000-grant-from-national-research-council-of-canada-902328.html Mon, 09 Sep 2019 17:22:00 -0400 https://ca.proactiveinvestors.com/companies/news/902328/acasti-pharma-receives-750000-grant-from-national-research-council-of-canada-902328.html Acasti Pharma awarded $750K by Canadian government to help develop flagship drug candidate CaPre https://ca.proactiveinvestors.com/companies/news/902305/acasti-pharma-awarded-750k-by-canadian-government-to-help-develop-flagship-drug-candidate-capre-902305.html Mon, 09 Sep 2019 13:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/902305/acasti-pharma-awarded-750k-by-canadian-government-to-help-develop-flagship-drug-candidate-capre-902305.html Acasti Pharma says on track to release new CaPre trial results by end of 2019 after fruitful 1Q https://ca.proactiveinvestors.com/companies/news/900759/acasti-pharma-says-on-track-to-release-new-capre-trial-results-by-end-of-2019-after-fruitful-1q-900759.html Wed, 14 Aug 2019 13:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/900759/acasti-pharma-says-on-track-to-release-new-capre-trial-results-by-end-of-2019-after-fruitful-1q-900759.html Acasti Pharma reiterated as Speculative Buy by Mackie after FDA setback news for competitor Amarin https://ca.proactiveinvestors.com/companies/news/900464/acasti-pharma-reiterated-as-speculative-buy-by-mackie-after-fda-setback-news-for-competitor-amarin-900464.html Fri, 09 Aug 2019 14:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/900464/acasti-pharma-reiterated-as-speculative-buy-by-mackie-after-fda-setback-news-for-competitor-amarin-900464.html Acasti Pharma to investors: We're not planning a capital raise https://ca.proactiveinvestors.com/companies/news/224529/acasti-pharma-to-investors-we-re-not-planning-a-capital-raise-224529.html Thu, 25 Jul 2019 20:31:00 -0400 https://ca.proactiveinvestors.com/companies/news/224529/acasti-pharma-to-investors-we-re-not-planning-a-capital-raise-224529.html Two prominent research firms initiate coverage on Acasti Pharma with Buy rating https://ca.proactiveinvestors.com/companies/news/223622/two-prominent-research-firms-initiate-coverage-on-acasti-pharma-with-buy-rating-223622.html Tue, 09 Jul 2019 19:41:00 -0400 https://ca.proactiveinvestors.com/companies/news/223622/two-prominent-research-firms-initiate-coverage-on-acasti-pharma-with-buy-rating-223622.html Mackie sees sales potential of Acasti's CaPre drug, maintains Speculative Buy rating https://ca.proactiveinvestors.com/companies/news/222977/mackie-sees-sales-potential-of-acasti-s-capre-drug-maintains-speculative-buy-rating-222977.html Thu, 27 Jun 2019 14:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/222977/mackie-sees-sales-potential-of-acasti-s-capre-drug-maintains-speculative-buy-rating-222977.html Acasti Pharma gets new Chinese patent that paves the way for its heart disease therapy https://ca.proactiveinvestors.com/companies/news/313887/acasti-pharma-gets-new-chinese-patent-that-paves-the-way-for-its-heart-disease-therapy-13887.html Wed, 26 Jun 2019 16:58:00 -0400 https://ca.proactiveinvestors.com/companies/news/313887/acasti-pharma-gets-new-chinese-patent-that-paves-the-way-for-its-heart-disease-therapy-13887.html Acasti Pharma is well-funded to complete Phase 3 trials of lead drug candidate CaPre https://ca.proactiveinvestors.com/companies/news/222868/acasti-pharma-is-well-funded-to-complete-phase-3-trials-of-lead-drug-candidate-capre-222868.html Wed, 26 Jun 2019 15:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/222868/acasti-pharma-is-well-funded-to-complete-phase-3-trials-of-lead-drug-candidate-capre-222868.html China grants new patent covering Acasti Pharma's flagship CaPre drug https://ca.proactiveinvestors.com/companies/news/222689/china-grants-new-patent-covering-acasti-pharma-s-flagship-capre-drug-222689.html Mon, 24 Jun 2019 14:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/222689/china-grants-new-patent-covering-acasti-pharma-s-flagship-capre-drug-222689.html Acasti Pharma says top-line results from TRILOGY 1 trial remain on track for December https://ca.proactiveinvestors.com/companies/news/221492/acasti-pharma-says-top-line-results-from-trilogy-1-trial-remain-on-track-for-december-221492.html Tue, 04 Jun 2019 17:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/221492/acasti-pharma-says-top-line-results-from-trilogy-1-trial-remain-on-track-for-december-221492.html Acasti Pharma eyes phase III success with double data readout towards year-end https://ca.proactiveinvestors.com/companies/news/313574/acasti-pharma-eyes-phase-iii-success-with-double-data-readout-towards-year-end-13574.html Tue, 04 Jun 2019 15:18:00 -0400 https://ca.proactiveinvestors.com/companies/news/313574/acasti-pharma-eyes-phase-iii-success-with-double-data-readout-towards-year-end-13574.html Acasti Pharma CEO says its CaPre could become a best-in-class omega-3 therapeutic https://ca.proactiveinvestors.com/companies/news/221420/acasti-pharma-ceo-says-its-capre-could-become-a-best-in-class-omega-3-therapeutic-221420.html Mon, 03 Jun 2019 19:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/221420/acasti-pharma-ceo-says-its-capre-could-become-a-best-in-class-omega-3-therapeutic-221420.html Acasti Pharma has global ambitions for its CaPre Omega-3 therapeutic https://ca.proactiveinvestors.com/companies/news/220988/acasti-pharma-has-global-ambitions-for-its-capre-omega-3-therapeutic-220988.html Tue, 28 May 2019 12:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/220988/acasti-pharma-has-global-ambitions-for-its-capre-omega-3-therapeutic-220988.html Acasti Pharma granted allowance for patents in 3 more countries for drug candidate Capre https://ca.proactiveinvestors.com/companies/news/313375/acasti-pharma-granted-allowance-for-patents-in-3-more-countries-for-drug-candidate-capre-13375.html Thu, 16 May 2019 10:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/313375/acasti-pharma-granted-allowance-for-patents-in-3-more-countries-for-drug-candidate-capre-13375.html Acasti Pharma Inc receives new patents in Israel, Mexico and Chile as it advances its cardiovascular drug https://ca.proactiveinvestors.com/companies/news/220345/acasti-pharma-inc-receives-new-patents-in-israel-mexico-and-chile-as-it-advances-its-cardiovascular-drug-220345.html Wed, 15 May 2019 15:19:00 -0400 https://ca.proactiveinvestors.com/companies/news/220345/acasti-pharma-inc-receives-new-patents-in-israel-mexico-and-chile-as-it-advances-its-cardiovascular-drug-220345.html Acasti Pharma expects top-line results on heart disease therapy by year's end https://ca.proactiveinvestors.com/companies/news/313234/acasti-pharma-expects-top-line-results-on-heart-disease-therapy-by-year-s-end-13234.html Mon, 06 May 2019 19:37:00 -0400 https://ca.proactiveinvestors.com/companies/news/313234/acasti-pharma-expects-top-line-results-on-heart-disease-therapy-by-year-s-end-13234.html Acasti Pharma says CaPre drug successfully reduces triglycerides https://ca.proactiveinvestors.com/companies/news/103456/acasti-pharma-says-capre-drug-successfully-reduces-triglycerides--57114.html Mon, 29 Sep 2014 18:14:00 -0400 https://ca.proactiveinvestors.com/companies/news/103456/acasti-pharma-says-capre-drug-successfully-reduces-triglycerides--57114.html